Takeda Pharmaceutical (TAK) Operating Margin (2017 - 2026)
Takeda Pharmaceutical (TAK) recorded quarterly Operating Margin of 1.24% in Q1 2026, down 106.78% quarter-over-quarter from 18.36% in Q4 2025, and down 3289.0% on a YoY basis from 0.04% in Q1 2025.
Takeda Pharmaceutical (TAK) Operating Margin (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Operating Margin history runs 10 years deep, the most recent figure standing at 1.24% for Q1 2026.
- In Q1 2026, Operating Margin fell 3289.0% year-over-year to 1.24%; the TTM figure through Mar 2026 stood at 22.49% (down 252.0% YoY), while the FY2026 annual figure was 9.07%, up 159.0% from the prior year.
- Operating Margin was 1.24% for Q1 2026 at Takeda Pharmaceutical, down from 18.36% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 31.65% in Q1 2025 to a low of 1.24% in Q1 2026.
- Historically, Operating Margin has averaged 18.47% across 5 years, with a median of 18.0% in 2024.
- The sharpest annual moves came in 2025 and 2026: Operating Margin soared 3261 bps in 2025, then slumped 3289 bps in 2026.
- A 5-year view of Operating Margin shows it stood at 13.4% in 2022, then surged by 66 bps to 22.24% in 2023, then dropped by 19 bps to 18.0% in 2024, then advanced by 2 bps to 18.36% in 2025, then plunged by 107 bps to 1.24% in 2026.
- The last three Operating Margin figures came in at 1.24% (Q1 2026), 18.36% (Q4 2025), and 28.52% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | -1.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24% |
| Dec 31, 2025 | 18.36% |
| Sep 30, 2025 | 28.52% |
| Jun 30, 2025 | 28.72% |
| Mar 31, 2025 | 31.65% |
| Dec 31, 2024 | 18.00% |
| Sep 30, 2024 | 28.52% |
| Jun 30, 2024 | 13.77% |
| Mar 31, 2024 | -0.96% |
| Dec 31, 2023 | 22.24% |
| Sep 30, 2023 | 29.65% |
| Jun 30, 2023 | 15.92% |
| Mar 31, 2023 | 15.93% |
| Dec 31, 2022 | 13.40% |
| Sep 30, 2022 | 10.42% |
| Jun 30, 2022 | 15.48% |
| Mar 31, 2022 | 25.56% |
| Dec 31, 2021 | 12.92% |
| Sep 30, 2021 | 11.53% |
| Jun 30, 2021 | 26.17% |